Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell wall biosynthesis is the process by which bacteria construct their protective cell wall, primarily composed of peptidoglycan. This pathway is essential for bacterial survival and is a major target for antibiotics. The process involves cytoplasmic synthesis of nucleotide precursors, membrane-associated formation and transport of lipid-linked intermediates, and extracellular polymerization and cross-linking of glycan chains. Key enzymes include glycosyltransferases, transpeptidases (PBPs), and autolysins. Antibiotic resistance can arise through various mechanisms, including β-lactamase production and PBP mutations.
Inhibition of peptidoglycan synthesis enzymes (e.g., transpeptidases, glycosyltransferases) or binding to peptidoglycan precursors (e.g., Lipid II) disrupting cell wall formation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Cell Wall Biosynthesis.